Microbiome Immunotherapy Toxicity and Response Evaluation

UNKNOWN

Identifier: CI-TRIAL-00064019
Entity page: /trial/NCT04107168 ↗
Edges: 9

Neighbours: 2 cancers7 drugs
Drawn: 9 of 9 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Microbiome Immunotherapy Toxicity and Response Evaluation condition of …CONDITION_OFderived2 of 2
← condition of	Malignant Lung Neoplasm registry condition “Lung Cancer” mapped CURATED_EXACT	—	—	Malignant Lung Neoplasm	1	Observed	clinicaltrials	graph →
← condition of	Melanoma registry condition “Melanoma” mapped ONTOLOGY_EXACT	—	—

Microbiome Immunotherapy Toxicity and Response Evaluation intervention of …INTERVENTION_OFderived7 of 7
← intervention of	Atezolizumabmonoclonal antibody registry intervention “Atezolizumab” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Bevacizumabmonoclonal antibody registry intervention “Bevacizumab” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Durvalumabmonoclonal antibody registry intervention “Durvalumab” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Ipilimumabmonoclonal antibody registry intervention “Ipilimumab” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Nivolumabmonoclonal antibody registry intervention “Nivolumab” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Pembrolizumabmonoclonal antibody registry intervention “Pembrolizumab” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Tremelimumabmonoclonal antibody registry intervention “Tremelimumab” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →

Microbiome Immunotherapy Toxicity and Response Evaluation intervention of …INTERVENTION_OFderived7 of 7

← intervention of

Atezolizumabmonoclonal antibody

registry intervention “Atezolizumab” (DRUG) mapped ALIAS

—

not mapped

Observed

clinicaltrials

graph →

← intervention of

Bevacizumabmonoclonal antibody

registry intervention “Bevacizumab” (DRUG) mapped ALIAS